Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan

Shunsuke Furuta, Afzal N. Chaudhry, Yoshitomo Hamano, Shouichi Fujimoto, Hiroko Nagafuchi, Hirofumi Makino, Seiichi Matsuo, Shoichi Ozaki, Tomomi Endo, Eri Muso, Chiharu Ito, Eiji Kusano, Mieko Yamagata, Kei Ikeda, Daisuke Kashiwakuma, Itsuo Iwamoto, Kerstin Westman, David Jayne

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Objective. There are differences between Europe and Japan in the incidence and antineutrophil cytoplasmic antibody (ANCA) serotype of patients with microscopic polyangiitis (MPA). However, differences in phenotype or outcome have not been explored. We aimed to identify differences in phenotype and outcome of MPA between Europe and Japan. Methods. Sequential cohorts of patients with MPA and renal limited vasculitis were collected from European and Japanese centers (n = 147 and n = 312, respectively). Trial databases from the European Vasculitis Society and the Japanese patients with Myeloperoxidase (MPO)-ANCA-Associated Vasculitis (JMAAV) trial were studied (n = 254 and n = 48, respectively). We evaluated baseline characteristics including ANCA status and organ involvement, treatment, survival, and renal survival. Differences in survival and renal survival were studied using multivariate analysis. Results. The non-trial cohorts showed patients with MPA in Japan had a higher age at onset, more frequent MPO-ANCA positivity, lower serum creatinine, and more frequent interstitial pneumonitis than those in Europe (all p < 0.01). Comparisons between the trial databases demonstrated similar results. Cumulative patient survival and renal survival rates were not different between Europe and Japan (p = 0.71 and p = 0.38, respectively). Multivariate analysis identified age at onset, serum creatinine, gastrointestinal, and respiratory involvement as factors with higher risk of death. For endstage renal failure, serum creatinine and use of plasma exchange were identified as factors with higher risk, and immunosuppressant use as lower risk factors. Conclusion. Phenotypes in patients with MPA were different between Europe and Japan. However, the outcomes of patient survival and renal survival were similar. (First Release Jan 15 2014; J Rheumatol 2014;41:325-33; doi:10.3899/jrheum.130602).

Original languageEnglish
Pages (from-to)325-333
Number of pages9
JournalJournal of Rheumatology
Volume41
Issue number2
DOIs
Publication statusPublished - Feb 1 2014

Fingerprint

Microscopic Polyangiitis
Japan
Antineutrophil Cytoplasmic Antibodies
Phenotype
Kidney
Vasculitis
Creatinine
Survival
Age of Onset
Peroxidase
Multivariate Analysis
Serum
Databases
Plasma Exchange
Interstitial Lung Diseases
Immunosuppressive Agents
Renal Insufficiency
Survival Rate
Incidence

Keywords

  • ANCA-associated vasculitis
  • Europe
  • Japan
  • Microscopic polyangiitis
  • Outcome
  • Phenotype

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

Furuta, S., Chaudhry, A. N., Hamano, Y., Fujimoto, S., Nagafuchi, H., Makino, H., ... Jayne, D. (2014). Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan. Journal of Rheumatology, 41(2), 325-333. https://doi.org/10.3899/jrheum.130602

Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan. / Furuta, Shunsuke; Chaudhry, Afzal N.; Hamano, Yoshitomo; Fujimoto, Shouichi; Nagafuchi, Hiroko; Makino, Hirofumi; Matsuo, Seiichi; Ozaki, Shoichi; Endo, Tomomi; Muso, Eri; Ito, Chiharu; Kusano, Eiji; Yamagata, Mieko; Ikeda, Kei; Kashiwakuma, Daisuke; Iwamoto, Itsuo; Westman, Kerstin; Jayne, David.

In: Journal of Rheumatology, Vol. 41, No. 2, 01.02.2014, p. 325-333.

Research output: Contribution to journalArticle

Furuta, S, Chaudhry, AN, Hamano, Y, Fujimoto, S, Nagafuchi, H, Makino, H, Matsuo, S, Ozaki, S, Endo, T, Muso, E, Ito, C, Kusano, E, Yamagata, M, Ikeda, K, Kashiwakuma, D, Iwamoto, I, Westman, K & Jayne, D 2014, 'Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan', Journal of Rheumatology, vol. 41, no. 2, pp. 325-333. https://doi.org/10.3899/jrheum.130602
Furuta, Shunsuke ; Chaudhry, Afzal N. ; Hamano, Yoshitomo ; Fujimoto, Shouichi ; Nagafuchi, Hiroko ; Makino, Hirofumi ; Matsuo, Seiichi ; Ozaki, Shoichi ; Endo, Tomomi ; Muso, Eri ; Ito, Chiharu ; Kusano, Eiji ; Yamagata, Mieko ; Ikeda, Kei ; Kashiwakuma, Daisuke ; Iwamoto, Itsuo ; Westman, Kerstin ; Jayne, David. / Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan. In: Journal of Rheumatology. 2014 ; Vol. 41, No. 2. pp. 325-333.
@article{8bfce520a3fd410ca4476481c000db5b,
title = "Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan",
abstract = "Objective. There are differences between Europe and Japan in the incidence and antineutrophil cytoplasmic antibody (ANCA) serotype of patients with microscopic polyangiitis (MPA). However, differences in phenotype or outcome have not been explored. We aimed to identify differences in phenotype and outcome of MPA between Europe and Japan. Methods. Sequential cohorts of patients with MPA and renal limited vasculitis were collected from European and Japanese centers (n = 147 and n = 312, respectively). Trial databases from the European Vasculitis Society and the Japanese patients with Myeloperoxidase (MPO)-ANCA-Associated Vasculitis (JMAAV) trial were studied (n = 254 and n = 48, respectively). We evaluated baseline characteristics including ANCA status and organ involvement, treatment, survival, and renal survival. Differences in survival and renal survival were studied using multivariate analysis. Results. The non-trial cohorts showed patients with MPA in Japan had a higher age at onset, more frequent MPO-ANCA positivity, lower serum creatinine, and more frequent interstitial pneumonitis than those in Europe (all p < 0.01). Comparisons between the trial databases demonstrated similar results. Cumulative patient survival and renal survival rates were not different between Europe and Japan (p = 0.71 and p = 0.38, respectively). Multivariate analysis identified age at onset, serum creatinine, gastrointestinal, and respiratory involvement as factors with higher risk of death. For endstage renal failure, serum creatinine and use of plasma exchange were identified as factors with higher risk, and immunosuppressant use as lower risk factors. Conclusion. Phenotypes in patients with MPA were different between Europe and Japan. However, the outcomes of patient survival and renal survival were similar. (First Release Jan 15 2014; J Rheumatol 2014;41:325-33; doi:10.3899/jrheum.130602).",
keywords = "ANCA-associated vasculitis, Europe, Japan, Microscopic polyangiitis, Outcome, Phenotype",
author = "Shunsuke Furuta and Chaudhry, {Afzal N.} and Yoshitomo Hamano and Shouichi Fujimoto and Hiroko Nagafuchi and Hirofumi Makino and Seiichi Matsuo and Shoichi Ozaki and Tomomi Endo and Eri Muso and Chiharu Ito and Eiji Kusano and Mieko Yamagata and Kei Ikeda and Daisuke Kashiwakuma and Itsuo Iwamoto and Kerstin Westman and David Jayne",
year = "2014",
month = "2",
day = "1",
doi = "10.3899/jrheum.130602",
language = "English",
volume = "41",
pages = "325--333",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "2",

}

TY - JOUR

T1 - Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan

AU - Furuta, Shunsuke

AU - Chaudhry, Afzal N.

AU - Hamano, Yoshitomo

AU - Fujimoto, Shouichi

AU - Nagafuchi, Hiroko

AU - Makino, Hirofumi

AU - Matsuo, Seiichi

AU - Ozaki, Shoichi

AU - Endo, Tomomi

AU - Muso, Eri

AU - Ito, Chiharu

AU - Kusano, Eiji

AU - Yamagata, Mieko

AU - Ikeda, Kei

AU - Kashiwakuma, Daisuke

AU - Iwamoto, Itsuo

AU - Westman, Kerstin

AU - Jayne, David

PY - 2014/2/1

Y1 - 2014/2/1

N2 - Objective. There are differences between Europe and Japan in the incidence and antineutrophil cytoplasmic antibody (ANCA) serotype of patients with microscopic polyangiitis (MPA). However, differences in phenotype or outcome have not been explored. We aimed to identify differences in phenotype and outcome of MPA between Europe and Japan. Methods. Sequential cohorts of patients with MPA and renal limited vasculitis were collected from European and Japanese centers (n = 147 and n = 312, respectively). Trial databases from the European Vasculitis Society and the Japanese patients with Myeloperoxidase (MPO)-ANCA-Associated Vasculitis (JMAAV) trial were studied (n = 254 and n = 48, respectively). We evaluated baseline characteristics including ANCA status and organ involvement, treatment, survival, and renal survival. Differences in survival and renal survival were studied using multivariate analysis. Results. The non-trial cohorts showed patients with MPA in Japan had a higher age at onset, more frequent MPO-ANCA positivity, lower serum creatinine, and more frequent interstitial pneumonitis than those in Europe (all p < 0.01). Comparisons between the trial databases demonstrated similar results. Cumulative patient survival and renal survival rates were not different between Europe and Japan (p = 0.71 and p = 0.38, respectively). Multivariate analysis identified age at onset, serum creatinine, gastrointestinal, and respiratory involvement as factors with higher risk of death. For endstage renal failure, serum creatinine and use of plasma exchange were identified as factors with higher risk, and immunosuppressant use as lower risk factors. Conclusion. Phenotypes in patients with MPA were different between Europe and Japan. However, the outcomes of patient survival and renal survival were similar. (First Release Jan 15 2014; J Rheumatol 2014;41:325-33; doi:10.3899/jrheum.130602).

AB - Objective. There are differences between Europe and Japan in the incidence and antineutrophil cytoplasmic antibody (ANCA) serotype of patients with microscopic polyangiitis (MPA). However, differences in phenotype or outcome have not been explored. We aimed to identify differences in phenotype and outcome of MPA between Europe and Japan. Methods. Sequential cohorts of patients with MPA and renal limited vasculitis were collected from European and Japanese centers (n = 147 and n = 312, respectively). Trial databases from the European Vasculitis Society and the Japanese patients with Myeloperoxidase (MPO)-ANCA-Associated Vasculitis (JMAAV) trial were studied (n = 254 and n = 48, respectively). We evaluated baseline characteristics including ANCA status and organ involvement, treatment, survival, and renal survival. Differences in survival and renal survival were studied using multivariate analysis. Results. The non-trial cohorts showed patients with MPA in Japan had a higher age at onset, more frequent MPO-ANCA positivity, lower serum creatinine, and more frequent interstitial pneumonitis than those in Europe (all p < 0.01). Comparisons between the trial databases demonstrated similar results. Cumulative patient survival and renal survival rates were not different between Europe and Japan (p = 0.71 and p = 0.38, respectively). Multivariate analysis identified age at onset, serum creatinine, gastrointestinal, and respiratory involvement as factors with higher risk of death. For endstage renal failure, serum creatinine and use of plasma exchange were identified as factors with higher risk, and immunosuppressant use as lower risk factors. Conclusion. Phenotypes in patients with MPA were different between Europe and Japan. However, the outcomes of patient survival and renal survival were similar. (First Release Jan 15 2014; J Rheumatol 2014;41:325-33; doi:10.3899/jrheum.130602).

KW - ANCA-associated vasculitis

KW - Europe

KW - Japan

KW - Microscopic polyangiitis

KW - Outcome

KW - Phenotype

UR - http://www.scopus.com/inward/record.url?scp=84893540661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893540661&partnerID=8YFLogxK

U2 - 10.3899/jrheum.130602

DO - 10.3899/jrheum.130602

M3 - Article

VL - 41

SP - 325

EP - 333

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 2

ER -